Besides, as nutraceuticals and functional food ingredients have been verified beneficial to vascular health may represent useful compounds that are able to reduce the overall cardiovascular risk induced by dyslipidemia by acting parallel to medicine or as adjuvants in case of failure or in situations where medicine cannot be used, using apoA5 and nutraceuticals as a combined therapy will become a new treatment. Here, APOA5 is linked to metabolic syndrome.